What is left ventricular hypertrophy and is there a reason to regress left ventricular hypertrophy?
Weir
Matthew R
MR
Division of Nephrology, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD 21202, USA. mweir@medicine.umaryland.edu
Townsend
Raymond R
RR
D000959:Antihypertensive Agents / Q000627:therapeutic use; D001011:Aorta / Q000503:physiopathology; D001794:Blood Pressure / Q000502:physiology*; D003131:Combined Modality Therapy; D016757:Death, Sudden, Cardiac / Q000453:epidemiology; D004035:Diet Therapy; D004548:Elasticity / Q000502:physiology; D005081:Exercise Therapy; D006333:Heart Failure / Q000453:epidemiology; D006801:Humans; D017379:Hypertrophy, Left Ventricular / Q000150:complications / Q000503:physiopathology* / Q000628:therapy*; D009203:Myocardial Infarction / Q000453:epidemiology; D012307:Risk Factors
D000959:Antihypertensive Agents
J Hypertens. 1995 Sep;13(9):943-52
8586828
Circulation. 2006 Mar 7;113(9):1213-25
16476843
J Hypertens. 1999 Jan;17(1):1-4
10100086
N Engl J Med. 1990 May 31;322(22):1561-6
2139921
J Am Coll Cardiol. 2007 Jul 3;50(1):1-13
17601538
Circulation. 2001 Oct 23;104(17):2039-44
11673343
Circulation. 1983 Jul;68(1):50-8
6851054
J Am Coll Cardiol. 2004 Jun 16;43(12):2207-15
15193681
Lancet. 2003 Apr 5;361(9364):1149-58
12686036
Fundam Clin Pharmacol. 2008 Jun;22(3):241-6
18485143
Circulation. 1995 Feb 1;91(3):698-706
7828296
Curr Opin Nephrol Hypertens. 2007 May;16(3):261-6
17420671
Circulation. 1985 Feb;71(2):202-10
3965165
Hypertension. 2008 Jun;51(6):1476-82
18426997
Eur Heart J. 2006 Nov;27(21):2588-605
17000623
N Engl J Med. 2008 Dec 4;359(23):2417-28
19052124
JAMA. 1996 May 15;275(19):1507-13
8622227
Hypertension. 2005 Jul;46(1):200-4
15911742
Hypertension. 2004 Jun;43(6):1239-45
15123572
Am J Med. 2003 Jul;115(1):41-6
12867233
J Am Coll Cardiol. 1998 Nov;32(5):1454-9
9809962
Ann Intern Med. 1992 Nov 15;117(10):831-6
1416558
Am J Hypertens. 2005 Jan;18(1 Pt 2):19S-22S
15683728